The NMDA receptor NR2B subunit: A valid therapeutic target for multiple CNS pathologies

Current Medicinal Chemistry

Volumn 11, Issue 3, 2004, Pages 389-396

  Chazot, Paul L ^a  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

CNS; Ifenprodil; Neuropathologies; NMDA receptors; NR2B

Indexed keywords

1 (4 CHLOROPHENYL) 2 METHYL 6 METHYOXY 7 HYDROXY 1,2,3,4 TETRAHYDROISOQUINOLINE; 4 (3 PHOSPHONOALLYL) 2 PIPERAZINECARBOXYLIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; ALPHA (4 HYDROXYPHENYL) BETA METHYL 4 (PHENYLMETHYL) 1 PIPERIDINE PROPANOL; ALPHA 1 ADRENERGIC RECEPTOR; ALTEPLASE; AMANTADINE; CO 101244; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DIZOCILPINE; EFAPROXIRAL; ELIPRODIL; GLUTAMIC ACID; HALOPERIDOL; IFENPRODIL; LEVODOPA; LITHIUM; MDL 1001543; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PD 174494; PD 196860; RECEPTOR SUBUNIT; RO 04 5595; RO 256981; RO 63 1908; SPERMIDINE; TRAXOPRODIL; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANALGESIC ACTIVITY; BINDING SITE; BIPOLAR DISORDER; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC PAIN; CLINICAL TRIAL; DEMENTIA; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DYSKINESIA; EPILEPSY; HEAD INJURY; HUMAN; HUNTINGTON CHOREA; NONHUMAN; PARKINSON DISEASE; PHARMACOPHORE; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PSYCHOSIS; RAT; RECEPTOR AFFINITY; REVIEW; STROKE; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; CENTRAL NERVOUS SYSTEM DISEASES; COGNITION; DRUG DELIVERY SYSTEMS; HUMANS; NEUROPROTECTIVE AGENTS; PHENOLS; PHOSPHORYLATION; PIPERIDINES; PROTEIN SUBUNITS; RECEPTORS, N-METHYL-D-ASPARTATE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 1242351945     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867043456061     Document Type: Review

References (94)

1. Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S.F Pharm. Revs., 1999, 51, 7.
2. Kemp, J.; McKernan, R. Nature Neurosci. (Suppl.), 2002, 5, 1039.
3. Chazot, P.L.; Hawkins, L.M. Investigational. Drugs 1999, 12, 1313.
4. Chenard, B.; Menniti, F.S. Curr. Pharm. Des. 1999, 5, 381.
5. Hawkins, L.M.; Chazot, P.L.; Stephenson, F.A. J. Biol. Chem. 1999, 274, 27211.
6. Chatterton, J.E.; Awobuluyi, M.; Premkumar, L.S.; Takahashi, H.; Talantova, M.; Shin, Y.; Cui, J.; Tu, S.; Sevarino, K.A.; Nakanishi, N.; Tong, G.; Lipton, S.A.; Zhang, D. Nature 2002, 14, 793.
7. Cull-Candy, S.; Brickley, S.; Farrant, M. Curr. Opinion in Neurobiology 2001 11, 327.
8. Vicini, S.; Wang, J.F.; Li, J.H.; Zhu, W.J.; Wang, Y.H.; Luo, J.H.; Wolfe, B.B.; Grayson, D.R. J. Neurophysiol. 1998, 79, 555.
9. Tovar, K.R.; Westbrook, G.L. J. Neurosci. 1999, 19, 4180.
10. Chazot, P.L.; Stephenson, F.A. J. Neurochem. 1997, 69, 2138.
11. Blahos, J. II; Wenthold, R.L. J. Biol. Chem. 1996, 271, 15669.
12. Sheng, M.; Cummings, J.; Roldan, L.A.; Jan, Y.N.; Jan, L.Y. Nature (Lond) 1994, 368, 144.
13. Dunah, A.W.; Wang, Y.; Yasuda, R.P.; Kameyama, K.; Huganir, R.L.; Wolfe, B.B.; Standaert, D.G. Mol. Pharmacol. 2000, 57, 342.
14. Laurie, D.J.; Seeburg, P.H. Eur. J. Pharmacol. 1994, 268, 335.
15. Thompson, C.L.; Drewery, D.L.; Atkins, H.D.; Stephenson, F.A.; Chazot, PL Neurosci. Letts. 2000, 283, 85.
16. Thompson, C.L.; Drewery, D.L.; Atkins, H.D.; Stephenson, F.A.; Chazot, P.L. Mol. Brain Res. 2002, 102, 55.
17. Dunah, A.W.; Yasuda, R.P.; Wang, Y.H.; Luo, J.; Davila-Garcia, M.; Gbadegesin, M.; Vicini, S.; Wolfe, B.B. J. Neurochem. 1996, 67, 2335.
18. Marvizon, J.C.; McRoberts, J.A.; Ennes, H.S.; Song, B.; Wang, X.; Jinton, L.; Corneliussen, B.; Mayer, E.A. J. Comp. Neurol. 2002, 446, 325.
19. Momiyama, A. J. Physiol. 2000, 523, 621.
20. Ito, I.; Futai, K.; Katagiri, H.; Watanabe, M.; Sakimura, K.; Mishina, M.; Sugiyama, H. J. Physiol. 1997, 500, 401.
21. Hardingham, G.E.; Fukunaga, Y.; Bading, H. Nat. Neurosci. 2002, 5, 405.
22. Tingley, W.G.; Ehlers, M.D.; Kameyama, K.; Doherty, C.; Ptak, J.B.; Riley, C.T.; Huganir, R.L. J. Biol. Chem. 1997, 272, 5157.
23. Soren, Leonard, A.; Hell, J.W. J. Biol. Chem. 1997, 272, 12107.
24. Ali, D.W.; Satter, M.W. Curr. Opin. Neurobiol. 2001, 11, 336.
25. Lu, W.Y.; Xiong, Z.G.; Lei, S.; Orser, B.A.; Dudek, E.; Browning, M.D.; MacDonald, J.F. Nat. Neurosci. 1999, 2, 331.
26. Grosshans, D.R.; Browning, M.D. J. Neurochem. 2001, 76, 737.
27. Nakazawa, T.; Komai, S.; Tezuka, T.; Hisatsune, C.; Umemori, H.; Semba, K.; Mishina, M.; Manabe, T.; Yamamoto, T. J. Biol. Chem. 2001, 276, 693.
28. Williams, K.T. Mol. Pharmacol. 1993, 44, 851.
29. Kew, J.N.; Richards, J.G.; Motel, V.; Kemp, J.A. J. Neurosci. 1998, 18, 1935.
30. Zheng, F.; Erreger, K.; Low, C.M.; Banke, T.; Lee, C.J.; Conn, P.J.; Traynelis, S.F. Nat. Neurosci. 2001, 4, 894.
31. Nikam, S.S.; Meltzer, L.T. Curr. Pharm. Design 2002, 8, 845.
32. Chenard, B.L.; Shalaby, I.A.; Koe, B.K.; Ronau, R.T.; Butler, T.W.; Prochniak, M.A.; Schmidt, A.W.; Fox, C. J. Med. Chem. 1991, 34, 3085.
33. Pinard, E.; Alanine, A.; Bourson, A.; Buttlemann, B.; Gill, R.; Heitz, M.-P.; Jaeschke, G.; Mutel, V.; Trube, G.; Wyler, R. Bioorg. Med. Chem. Letts. 2001, 11, 2173.
34. Mutel, V.; Buchy, D.; Klingelschmidt, A.; Messer, J.; Bleuel, Z.; Kemp, J.A.; Richards, J.G J. Neurochem. 1998, 7, 2147.
35. Mott, D.D.; Doherty, J.J.; Zhang, S.; Washburn, M.S.; Fendley, M.J.; Lyuboslavsky, P.; Traynelis, S.F.; Dingledine, R. Nature Neurosci. 1998, 1, 659.
36. Brimecombe, J.C.; Boeckman, F.A.; Aizenman, E. Proc. Natl. Acad. Sci. (USA) 1997 94, 11019.
37. Boeckman, F.A.; Aizenman, E. J. Pharmacol. Exp. Ther. 1996, 279, 515.
38. Chazot, P.L.; Lawrence, S.; Thompson, C.L. Neuropharmacology 2002, 42, 319.
39. Stocca, G.; Vicini, S. J. Physiol. 1998, 507, 13.
40. Lynch, D.R.; Shim, S.S.; Seifert, K.M.; Kurapathi, S.; Motel, V.; Gallagher, M.J.; Guttmann, R.P. Eur. J. Pharmacol. 2001, 416, 185.
41. Perin-Dureau, F.; Rachline, J.; Neyton, J.; Paoletti, P. J. Neurosci. 2002, 22, 5955.
42. Brimecombe, J.C.; Gallagher, M.J.; Lynch, D.R.; Aizenman, E. J. Pharmacol. Exp. Ther. 1998, 286, 627.
43. Gallagher, M.J.; Huang, H.; Grant, E.R.; Lynch, D.R. J. Biol. Chem. 1997 272, 24970.
44. Li, P.; Zhuo, M. Nature 1998, 393, 695.
45. Zhuo, M. Drug Discov. Today 2002, 7, 259.
46. Wainai, T.; Takeuchi, T.; Seo, N. Mishina, M. NeuroReport 2001, 12, 3169.
47. Karlsson, U.; Sjodin, J.; Angeby, Moller.; K, Johansson, S.; Wikstrom, L.; Nasstrom, J. Neuroscience 2002, 112, 861.
48. Wei, F.; Wang, G.D.; Kerchner, G.A.; Kim, S.J.; Xu, H.M.; Chen, Z.F.; Zhuo, M. Nat. Neurosci. 2001, 24, 164.
49. Chizh, B.A.; Reissmuller, E.; Schlutz, H.; Scheede, M.; Haase, G.; Englberger, W. Neuropharmacology 2001, 40, 212.
50. Tarnawa, I.; Kocsis, P.; Kavacs, G.; Horvarh, C.; Farkas, S. FENS meeting 2002, 50.23.
51. Guo, W.; Zou, S.; Guan, Y.; Ikeda, T.; Tal, M.; Dubner, R.; Ren, K. (2002) J Neurosci 2002, 22, 6208.
52. Boyce, S.; Wyatt, A.; Webb, J.K.; O'Donnell, R.; Mason, G.; Rigby, M.; Sirinathsinghji, D.; Hill, R.G.; Rupniak, N.M. Neuropharmacology 1999, 38, 611.
53. Taniguchi, K.; Shinjo, K.; Mizutani, M.; Shimada, K.; Ishikawa, T.; Menniti, F.S.; Nagahisa, A. Br. J. Pharmacol. 1997, 122, 809.
54. Fillhard, J.; Wiley, J.; Woodward, R.M.; Zhou, Z.-L.; Meltzer, L.T. Soc. Neurosci. Abstr. 1999, 25, 921.
55. Fillhard, J.; Kinsora, J.J.; Meltzer, L.T. Soc. Neurosci. Abstr. 2000, 26, 1646.
56. Nicole, O.; Docagne, F.; Ali, C.; Margaill, I.; Carmeliet, P.; MacKenzie, E.T.; Vivien, D.; Buisson, A. Nat. Med. 2001, 7, 59.
57. Gotti, B.; Duverger, D.; Berlin, J.; Carter, C.; Dupont, R.; Frost, J.; Gaudilliere, B.; MacKenzie, E.T.; Rousseau, J.; Scatton, B. J. Pharmacol. Exp. Ther. 1988, 247, 1211.
58. Toulmond, S.; Serrano, A.; Benavides, J.; Scatton, B. Brain Res. 1993, 620, 32.
59. Fischer, G.; Bourson, A.; Kemp, J.A.; Lorez, H.P. Soc. Neurosci. Abstr. 1996, 22, 1760.
60. Okiyama, K.; Smith, D.H.; White, W.F.; Richter, K.; McIntosh, T.K. J. Neurotrauma. 1997, 14, 211.
61. Tsuchida, E.; Rice, M.; Bullock, R. J. Neurotrauma. 1997, 14, 409.
62. Di, X.; Bullock, R.; Watson, J.; Fatouros, P.; Chenard, B.; White, F.; Corwin, F. Stroke 1997, 28, 2244.
63. Bullock, M.R.; Merchant, R.E.; Carmack, C.A.; Doppenberg, E.; Shah, A.K.; Wilner, K.D.; Ko, G.; Williams, S.A. Ann. N. Y. Acad. Sci. 1999, 890, 51.
64. Chazot, P.L. Curr. Opin. Invest. Drugs 2000, 1, 370.
65. Arias, C.; Montiel, T.; Pena, F.; Ferrera, P.; Tapia, R. Exp. Neurol. 2002, 177, 284.
66. Moussa, R.C.; Ikeda-Douglas, C.J.; Thakur, V.; Milgram, N.W.; Gurd, J.W. Mol. Brain Res. 2001, 95, 36.
67. Zeron, M.M.; Hansson, O.; Chen, N.; Wellington, C.L.; Leavitt, B.R.; Brundin, P.; Hayden, M.R.; Raymond, L.A. Neuron 2002, 33, 849.
68. Chen, N.; Luo, T.; Wellington, C.; Metzler, M.; McCutcheon, K.; Hayden, M.R.; Raymond, L.A. J. Neurochem. 1999, 72, 1890.
69. Sun, Y.; Savanenin, A.; Reddy, P.H.; Liu, Y.F. J. Biol. Chem. 2001, 276, 24713.
70. Gao, X.M.; Sakai, K.; Roberts, R.C.; Conley, R.R.; Dean, B.; Tamminga, C.A. Am. J. Psychiatry 2000, 157, 1141.
71. Grimwood, S.; Slater, P.; Deakin, J.F.; Hutson, P.H. NeuroReport 1999, 10, 461.
72. Miyatake, R.; Furukawa, A.; Suwaki, H. Mol. Psychiatry 2002, 7, 1101.
73. Hashimoto, R.; Hough, C.; Nakazawa, T.; Yamamoto, T.; Chuang, D.M. J. Neurochem. 2002 80, 589.
74. Blandini, F. Funct. Neurol. 2001, 16(Suppl. 4), 99.
75. Mitchell, I.J.; Carroll, C.B. Neurosci. Biobehav. Rev. 1997, 21, 469.
76. Gerlach, M.; Gsell, W.; W, Kornhuber, J.; Jellinger, K.; Krieger, V.; Pantucek, F.; Vock, R.; Riederer, P. Brain Res. 1996, 741, 142.
77. Dunah, A.W.; Wang, Y.; Yasuda, R.P.; Kameyama, K.; Huganir, R.L.; Wolfe, B.B.; Standaert, D.G. Mol. Pharmacol. 2000, 57, 342.
78. Chase, T.N.; Oh, J.D.; Konitsiotis, S. J. Neurol. 2000, 247 Suppl, 2, 36.
79. Meoni, P.; Bunnemann, B.H.; Kingsbury, A.E.; Trist, D.G.; Bowery, N.G.. Neuropharmacology 1999, 38, 625.
80. Stecce-Collier, K.; Chambers, L.K.; Jaw-Tsai, S.S.; Menniti, F.S.; Greenamyre, J.T. Exp. Neurol. 2000, 163, 239.
81. Bezard, E.; Brotchie, J.M.; Gross, C.E. Nat. Neurosci. 2001, 2, 577.
82. Rascol, O.; Payoux, P.; Ory, F.; Ferreira, J.J.; Brefel-Courbon, C.; Montastruc, J.L. Ann. Neurol. 2003, 53, S3.
83. Calabresi, P.; Giacomini, P.; Centonze, D.; Bernardi, G. Ann. Neurol. 2000, 47 (Suppl.), S60/68.
84. Luginger, E.; Wenning, G.K.; Bosch, S.; Poewe, W. Mov. Disord. 2000, 15, 873.
85. Blanchet, P.J.; Konitsiotis, S.; Whittemore, E.R.; Zhou, Z.L.; Woodward, R.M.; Chase, T.N. J. Pharmacol. Exp. Ther. 1999, 290, 1034.
86. Kostic, V.; Przedborski, S.; Flaster, E.; Sternic, N.; (1991) Neurology 1991, 41, 202.
87. Schrag, A.; Ben-Shlomo, Y.; Brown, R.; Marsden, C.D.; Quinn, N. Mov. Disord. 1998, 13, 85.
88. Piggott, M.A.; Perry, E.K.; Perry, R.H.; Court, J.A. Brain Res. 1992, 588, 277.
89. Chase, T.N.; Oh, J.D. Ann. Neurol. 2000, 47, 122.
90. Clayton, D.A.; Mesches, M.H.; Alvarez, E.; Bickford, P.C.; Browning, M.D. J. Neurosci 2002, 22, 3628.
91. Tang, Y.P.; Shimizu, E.; Duke, G.R.; Rampon, C.; Kerchner, G.A.; Zho, M.; Liu, G.; Tsien, J.Z. Nature 1999, 401, 63.
92. Guscott, M.; Clarke, H.; Murray, F.; Grimwood, S.; Hutson, P.H.; Bristow, L. FENS meeting 2002, 107, 13.
93. Rodrigues, S.M.; Schafe, G.E.; LeDoux, J.E. J. Neurosci. 2001, 21, 6889.
94. Chizh, B.A.; Headley, P.M.; Tzschentke, T.M. Trends Pharmacol. Sci. 2001, 22, 636.